Sustained disease control with aflibercept 8 mg: A turning point in the management of exudative retinal disease: Expert consenus. (2026). Ukrainian Journal of Ophthalmology , 2, 71-76. https://doi.org/10.31288/Ukr.j.ophthalmol.202627176